Home › China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China
 

Keywords :   


China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China

2013-08-25 10:18:37| Biotech - Topix.net

MicuRx Pharmaceuticals, a San Francisco-Shanghai antibiotics company, raised $25 million in Series B financing.

Tags: review big china accused

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11S
24.11
24.115
24.11SR
24.11 RC24.4.5
24.11115+128717dz
24.11lavaSUKALA 3
24.11508A
More »